Skip to main content
. 1997 Apr 1;94(7):3262–3267. doi: 10.1073/pnas.94.7.3262

Figure 1.

Figure 1

Vaccination of DBA/2 mice against P815 tumor challenge with the JAK-1 peptide SYFPEITHI. (a) The indicated amounts of peptide were administered per animal. The ratio of peptide to transferrin-coupled pLys200 referenced on pLys was 6.25:1 (wt/wt). (b) Vaccination with JAK-1 peptide and two pLys with dp = 16 (pLys16) or dp = 240 (pLys240). Per animal, 100 μg of peptide was applied in conjunction with 75 μg of pLys16 or 7.5 μg of pLys240.